AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach.
Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.
Company Details
- Employees
- 35
- Founded
- -
- Address
- 100 Ne Northlake Way,
- Industry
- Biotechnology
- Website
- http://www.altpep.com
- HQ
- Seattle, Washington
Altpep Questions
Altpep's website is http://www.altpep.com
Altpep's LinkedIn profile is https://www.linkedin.com/company/altpep
Altpep has
35 employees.
View email and phone details for 35
employees at Altpep.
Altpep's industry is
Biotechnology
Altpep's top competitors are
Cajal Therapeutics,
Hdt Bio,
Curi Bio,
Alpine Immune Sciences, Inc.,
A-Alpha Bio,
Xaira Therapeutics,
Umoja Biopharma,
Lumen Bioscience,
Variant Bio,
Bonum Therapeutics.
Altpep's categories are Biotechnology
Altpep's founding year is 2019
